Covidien — Merger or Acquisition (August 2014)
21 slides from Covidien's merger presentation, Aug 22, 2014
Slide 1: Global Town Hall Meeting with Chairman and CEO Omar Ishrak
Global Town Hall Meeting with Chairman and CEO Omar Ishrak August 22, 2014
Slide 2: Medtronic to Acquire Covidien
Medtronic to Acquire Covidien
Slide 3: The Medtronic Mission: A Shared Sense of Purpose
The Medtronic Mission: A Shared Sense of Purpose “ To contribute to human welfare…alleviate pain, restore health, and extend life… To direct our growth in the areas of maximum strength and ability…to continuously build on these areas through education and knowledge… To strive without reserve for the
Slide 4: Combination Results in Strategic Diversification
Combination Results in Strate ication Surgical Solutions Spine Respiratory & Diabetes Patient Care Cardiac Rhythm & Heart Failure Cor Structu
Slide 5: A Strong Strategic Fit
A Strong Strategic Fit Uniquely positioned to expand our industry-leading franchises through our three differentiated strategies: Therapy Innovation: Delivering strong launch cadence of meaningful therapies & and procedures Globalization: Addressing the inequities in healthcare access globally Econo
Slide 6: Three Key Benefits for Medtronic and Covidien
Three Key Benefits for Medtronic and Covidien Therapy Innovation 1. Strengthen and enhance Peripheral Vascular and Neuroscience portfolios 2. Leverage adjacencies in Medtronic Surgical Technologies and Covidien Surgical Solutions Therapy Innovation 3. Accelerate market adoption of early stage Covidi
Slide 7: Combined Company Immediately Accelerates Ability to Expand Global Access
Combined Company Immediately Accelerates Ability to Expand Global Access 150+ 300+ $3.7B ombined ies ons revenue ü Broader presence facilitates more rapid expansion ü Covidien products such as surgical tools and capital equipment are adopted earlier in hospitals, becoming a base for Medtronic chroni
Slide 8: Complementary Solutions Create Opportunities for Robust Integrated Health Offerings
Complementary Solutions Create Opportunities for Robust Integrated Health Offerings Value in hospita efficiencies Value in po acute setting
Slide 9: Integration Update
Integration, Update
Slide 10: Integration Update – Geoff Martha, SVP and Chief Integration Officer
Integration Update Geoff Martha SVP and Chief Integration Officer
Slide 11: Covidien Integration: Strategy for Success
Covidien Integration: Strategy for Success PRESERVE Achieve MDT & COV Strategic Plans Protect the front end Maintain business momentum at both companies Change vs. disruption Cost Reduction OPTIMIZE Rigorous execution vs. stretch targets Exceed our announced synergy targets and reinvest Optimized se
Slide 12: Integration Architecture Is In Place
Integration Architecture Is In Place Joint Steering Committee Medtronic Covidien Omar Ishrak Joe Almeida (CEO) Gary Ellis Bryan Hanson (EVP, Group Leader) Carol Surface Chuck Dockendorff (CFO) Mike Dunford (HR Leader) Core IMO leaders Extended IMO Geoff Martha and Bill Burke (COV) Advisory team to C
Slide 13: InSite: News and Perspective on the Covidien Integration
InSite: News and Perspective on the Covidien Integration Go to the Covidien Acquisition Tab on myMedtronic to learn more
Slide 14: Combined Impact
Combined Impact
Slide 15: Further Expanding Our Comprehensive Portfolio
Further Expanding Our Comprehensive Portfolio Neurological Ear, nose and throat Severe spasticity Sinus diseases Parkinson’s disease Structur hm Thyroid conditions Essential tremor Heart valve illation Otologic disorders Dystonia* Congenital t rates Sleep-disordered breathing Hydrocephalus dia) Pedi
Slide 16: Transforming Healthcare Around the World: $27 Billion Healthcare Leader
Transforming Healthcare Around the World to Improve More Lives Together: $27 Billion Healthcare Leader 87,000+ Employees Life-Changing Impact for Millions of Patients Every 3seconds
Slide 17: Global Town Hall Meeting with Chairman and CEO Omar Ishrak
Global Town Hall Meeting with Chairman and CEO Omar Ishrak August 22, 2014
Slide 18: Disclaimers
Disclaimers NO OFFER OR SOLICITATION This communication is not intended to and does not constitute an offer to sell or the solicitation of an offer to subscribe for or buy or an invitation to purchase or subscribe for any securities or the solicitation of any vote or approval in any jurisdiction pur
Slide 19: Disclaimers (cont'd)
Disclaimers (cont’d) PARTICIPANTS IN THE SOLICITATION Medtronic, New Medtronic and Covidien and certain of their respective directors and executive officers and employees may be considered participants in the solicitation of proxies from the respective shareholders of Medtronic and Covidien in respe
Slide 20: Disclaimers (cont'd): Cautionary Statement Regarding Forward-Looking Statements
Disclaimers (cont’d) Cautionary Statement Regarding Forward-Looking Statements Statements contained in this communication that refer to New Medtronic’s, Medtronic’s and/or Covidien’s estimated or anticipated future results, including estimated synergies, or other non-historical facts are forward-loo
Slide 21: Disclaimers (cont'd): Statement Required by the Irish Takeover Rules
Disclaimers (cont’d) Statement Required by the Irish Takeover Rules The directors of Medtronic accept responsibility for the information contained in this document. To the best of the knowledge and belief of the directors of Medtronic (who have taken all reasonable care to ensure that such is the ca